St Jude Medical Inc (STJ) Return on Assets ROA from the third quarter of 2016 to third quarter of 2015 and for the year 2016, Average High and Low, Fundamental Ratios from Oct 01 2016 to Oct 03 2015 - CSIMarket
CSIMarket
 


St Jude Medical Inc  (STJ)


St Jude Medical Inc's ROA from the third quarter of 2016 to the third quarter of 2015 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is St Jude Medical Inc's ROA in the third quarter of 2016?
St Jude Medical Inc achieved a return on average assets (ROA) of 5.32 % in its third quarter of 2016, which is below St Jude Medical Inc's average return on assets, which stands at 9.6%.

ROA decreased relative to the period ending Jul 02 2016, due to the decline in net income.

However, within the Healthcare sector 133 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2016 from 1206 to 1232.

What is ROA?



Return On Assets (Oct 01 2016)
III. Quarter
(Jul 02 2016)
II. Quarter
(Apr 02 2016)
I. Quarter
(Jan 02 2016)
IV. Quarter
(Oct 03 2015)
III. Quarter
Y / Y Total Assets Change 31.39 % 33.33 % 28.29 % 8.69 % -7.75 %
Y / Y Net Income Change -1.4 % -15.6 % -62.89 % -52.52 % -7.33 %
Net Income (TTM) in million 658 661 705 866 991
Return On Assets (TTM) 5.32 % 5.7 % 6.52 % 8.58 % 10.04 %
STJ's Total Ranking # 1232 # 1206 # # # 750
Total Assets (TTM) in million 12,658 12,552 13,095 11,125 9,634
Seq. Total Assets Change 0.84 % -4.15 % 17.71 % 15.48 % 2.34 %
Seq. Net Income Change -10.92 % 150.53 % -15.93 % -47.44 % -23.76 %



Return On Assets Company Ranking
Within: No.
Industry # 46
Sector # 134
Overall # 1083

Return On Assets Statistics
High Average Low
14.67 %
9.6 %
5.35 %
(Sep. 30, 2005)   (Oct 01 2016)





Financial Statements
St Jude Medical Inc's Assets $ 12,658 million STJ's Balance sheet
St Jude Medical Inc's Income $ 212 million Quarterly STJ's Income Statement
STJ's Income by Division See STJ's Income by Division



Annual Return On Assets (Jan 02 2016)
FY 2015
(FY 2014)
FY (Dec. 30, 2014)
(Dec 28 2013)
FY 2013
(FY 2012)
FY (Dec. 30, 2012)
(Dec 31 2011)
FY 2011
Y / Y Total Assets Change 27.99 % -0.4 % 10.54 % 2.95 % 5.12 %
Total Assets in million 13,064 10,207 10,248 9,271 9,005
Y / Y Net Income Change -9.32 % 38.01 % -7.98 % -8.94 % -9 %
Net Income in million 866 955 692 752 826
Annual Return On Assets 6.63 % 9.36 % 6.75 % 8.11 % 9.17 %




Comment on STJ's ROA in the fiscal year ending 2015
In the fiscal year 2015 St Jude Medical Inc's ROA decreased compared to previous year to 6.63 %, due to deterioration of net income -9.32 % to $866.00 million, from $955.00 million a year ago, as STJ's assets were $13,064.00 million.


More Return On Assets Ratios
STJ's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
STJ's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for STJ's Competitors
Subscribers only: Roa for St Jude Medical Inc's Suppliers
Subscribers only: Return On Assets for STJ's Customers

You may also want to know
STJ's Roi STJ's Inventory Turnover Ratio STJ's Growth Rates STJ's Dividend Comparisons
STJ's Profitability Ratios STJ's Asset Turnover Ratio STJ's Dividend Growth
STJ's Roe STJ's Valuation Ratios STJ's Financial Strength Ratios STJ's Dividend Payout Ratio



Companies with similar Return On Assets at Oct 01 2016, within Healthcare Sector ROA
Idexx Laboratories Inc  14.41 %
Globus Medical Inc   13.66 %
Meridian Bioscience Inc   13.55 %
Edwards Lifesciences Corporation  13.54 %
Phibro Animal Health Corporation  13.29 %
Lifevantage Corp  13.21 %
Star Equity Holdings Inc   13.06 %
Intuitive Surgical Inc   13.03 %
Regeneron Pharmaceuticals Inc   12.99 %
Healthcare Services Group Inc   12.96 %
Resmed Inc   12.69 %
Abaxis Inc  12.64 %
Chemed Corporation  12.42 %
Lineage Cell Therapeutics Inc   12.17 %
Incyte Corporation  11.87 %
Mimedx Group Inc   11.83 %
Cambrex Corp  11.60 %
Johnson and Johnson  11.60 %
Varian Medical Systems Inc   11.31 %
Waters Corporation  11.28 %
Myriad Genetics Inc   11.22 %
Lemaitre Vascular Inc   11.05 %
Pacific Health Care Organization Inc  11.03 %
Illumina Inc   10.79 %
Regenicin Inc   10.72 %
Heartbeam Inc   10.62 %
Electromed Inc   10.62 %
Bristol myers Squibb Company  10.51 %
Allergan plc  10.47 %
Pro dex Inc   10.47 %


Date modified: 2026-09-08T15:08:36+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.